Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-03-27-Speech-4-018"

PredicateValue (sorted: default)
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20030327.1.4-018"2
lpv:hasSubsequent
lpv:speaker
lpv:spoken text
"Mr President, congratulations to Mr Busquin and Mr Gérard Caudron. Gérard has worked quickly but he has not been sloppy or careless. We have been able to put across important points despite working quickly. This is innovation. This is a new use of Article 169 which will lead to considerable leverage, with EUR 200 million from the EU plus EUR 200 million from Member States and we hope for at least that much from industry. In this area the market has failed, as it so often does, and there has been, until now, a certain lack of public leadership, with a particular bottleneck in the clinical trials aspect of finding new products. We have heard that it is the biggest killer, that 5 million people die a year, 95% of them in poor countries. Yesterday, we grieved publicly for the victims of the irresponsible and immoral war in Iraq by wearing black armbands. We should be wearing them every day for the victims of these killer diseases. There is, of course, a multi-pronged attack. This point has been made by other speakers. Other actions are needed but this particular action is research. It is for clinical trials which will lead to the development of new products, in particular a new vaccine for tuberculosis, much better diagnostic tools, and combined medicines for HIV/AIDS which are easier to take and have fewer side effects. That is what we want at the end. That will be the outcome of these clinical trials. We have made the point that they must be targeted. Despite the complexity of the problem let us keep in mind the whole time what we want at the end. We must strengthen the clinical research capacities in developing countries. One of the tragedies of our planet is the waste of human intelligence and creativity in countries which have been politically discriminatory or else riven by poverty. We must encourage that intelligence and creativity by having infrastructure, training and everything else. Everything must be anchored in the developing countries with an understanding that, should we find these things, should we find a better vaccine for tuberculosis, better drugs for HIV/AIDS and better diagnostic tests, they will be available to those that need them. It would be the greatest obscenity to do this work, discover the products and then find that those who need them cannot use them. I am very pleased that has been emphasised and I thank Gérard Caudron very much for his work as well as, of course, Commissioner Busquin."@en1
lpv:spokenAs
lpv:unclassifiedMetadata

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz
3http://purl.org/linkedpolitics/rdf/spokenAs.ttl.gz

The resource appears as object in 2 triples

Context graph